nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—Phlebitis—Carboplatin—testicular cancer	0.0252	0.0252	CcSEcCtD
Cefotetan—Nephropathy toxic—Bleomycin—testicular cancer	0.0207	0.0207	CcSEcCtD
Cefotetan—Nephropathy toxic—Ifosfamide—testicular cancer	0.0177	0.0177	CcSEcCtD
Cefotetan—Nephropathy toxic—Cisplatin—testicular cancer	0.0153	0.0153	CcSEcCtD
Cefotetan—Nephropathy toxic—Etoposide—testicular cancer	0.014	0.014	CcSEcCtD
Cefotetan—Cholestasis—Ifosfamide—testicular cancer	0.0134	0.0134	CcSEcCtD
Cefotetan—Haemolytic anaemia—Chlorambucil—testicular cancer	0.0124	0.0124	CcSEcCtD
Cefotetan—Phlebitis—Vinblastine—testicular cancer	0.0119	0.0119	CcSEcCtD
Cefotetan—Prothrombin level increased—Epirubicin—testicular cancer	0.011	0.011	CcSEcCtD
Cefotetan—Aplastic anaemia—Dactinomycin—testicular cancer	0.0104	0.0104	CcSEcCtD
Cefotetan—Prothrombin level increased—Doxorubicin—testicular cancer	0.0102	0.0102	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Chlorambucil—testicular cancer	0.0101	0.0101	CcSEcCtD
Cefotetan—Phlebitis—Bleomycin—testicular cancer	0.01	0.01	CcSEcCtD
Cefotetan—Colitis—Ifosfamide—testicular cancer	0.00978	0.00978	CcSEcCtD
Cefotetan—Phlebitis—Dactinomycin—testicular cancer	0.00936	0.00936	CcSEcCtD
Cefotetan—Pancytopenia—Chlorambucil—testicular cancer	0.00917	0.00917	CcSEcCtD
Cefotetan—Neutropenia—Chlorambucil—testicular cancer	0.00903	0.00903	CcSEcCtD
Cefotetan—Vaginal moniliasis—Epirubicin—testicular cancer	0.00893	0.00893	CcSEcCtD
Cefotetan—Phlebitis—Ifosfamide—testicular cancer	0.00858	0.00858	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Epirubicin—testicular cancer	0.00857	0.00857	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Chlorambucil—testicular cancer	0.00854	0.00854	CcSEcCtD
Cefotetan—Hepatic function abnormal—Ifosfamide—testicular cancer	0.00846	0.00846	CcSEcCtD
Cefotetan—Body temperature increased—Carboplatin—testicular cancer	0.00844	0.00844	CcSEcCtD
Cefotetan—Pancytopenia—Vinblastine—testicular cancer	0.00841	0.00841	CcSEcCtD
Cefotetan—Vaginal moniliasis—Doxorubicin—testicular cancer	0.00827	0.00827	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Epirubicin—testicular cancer	0.00825	0.00825	CcSEcCtD
Cefotetan—Haemolytic anaemia—Ifosfamide—testicular cancer	0.00819	0.00819	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Doxorubicin—testicular cancer	0.00793	0.00793	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Doxorubicin—testicular cancer	0.00763	0.00763	CcSEcCtD
Cefotetan—Phlebitis—Cisplatin—testicular cancer	0.0074	0.0074	CcSEcCtD
Cefotetan—Agranulocytosis—Vinblastine—testicular cancer	0.00736	0.00736	CcSEcCtD
Cefotetan—Erythema multiforme—Chlorambucil—testicular cancer	0.00731	0.00731	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Dactinomycin—testicular cancer	0.00726	0.00726	CcSEcCtD
Cefotetan—Thrombocytosis—Epirubicin—testicular cancer	0.00725	0.00725	CcSEcCtD
Cefotetan—Haemoglobin—Vinblastine—testicular cancer	0.00712	0.00712	CcSEcCtD
Cefotetan—Pancytopenia—Bleomycin—testicular cancer	0.0071	0.0071	CcSEcCtD
Cefotetan—Haemorrhage—Vinblastine—testicular cancer	0.00708	0.00708	CcSEcCtD
Cefotetan—Haemolytic anaemia—Cisplatin—testicular cancer	0.00706	0.00706	CcSEcCtD
Cefotetan—Phlebitis—Etoposide—testicular cancer	0.00678	0.00678	CcSEcCtD
Cefotetan—Thrombocytosis—Doxorubicin—testicular cancer	0.00671	0.00671	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Ifosfamide—testicular cancer	0.00666	0.00666	CcSEcCtD
Cefotetan—Pancytopenia—Dactinomycin—testicular cancer	0.00662	0.00662	CcSEcCtD
Cefotetan—Neutropenia—Dactinomycin—testicular cancer	0.00652	0.00652	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Dactinomycin—testicular cancer	0.00616	0.00616	CcSEcCtD
Cefotetan—Pancytopenia—Ifosfamide—testicular cancer	0.00607	0.00607	CcSEcCtD
Cefotetan—Leukopenia—Chlorambucil—testicular cancer	0.00602	0.00602	CcSEcCtD
Cefotetan—Haemoglobin—Bleomycin—testicular cancer	0.00601	0.00601	CcSEcCtD
Cefotetan—Haemorrhage—Bleomycin—testicular cancer	0.00598	0.00598	CcSEcCtD
Cefotetan—Convulsion—Chlorambucil—testicular cancer	0.00583	0.00583	CcSEcCtD
Cefotetan—Agranulocytosis—Dactinomycin—testicular cancer	0.0058	0.0058	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Ifosfamide—testicular cancer	0.00565	0.00565	CcSEcCtD
Cefotetan—Leukopenia—Vinblastine—testicular cancer	0.00552	0.00552	CcSEcCtD
Cefotetan—Thrombocytopenia—Chlorambucil—testicular cancer	0.00538	0.00538	CcSEcCtD
Cefotetan—Convulsion—Vinblastine—testicular cancer	0.00534	0.00534	CcSEcCtD
Cefotetan—Agranulocytosis—Ifosfamide—testicular cancer	0.00532	0.00532	CcSEcCtD
Cefotetan—Erythema multiforme—Dactinomycin—testicular cancer	0.00528	0.00528	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Etoposide—testicular cancer	0.00526	0.00526	CcSEcCtD
Cefotetan—Pancytopenia—Cisplatin—testicular cancer	0.00523	0.00523	CcSEcCtD
Cefotetan—Discomfort—Vinblastine—testicular cancer	0.00519	0.00519	CcSEcCtD
Cefotetan—Haemoglobin—Ifosfamide—testicular cancer	0.00514	0.00514	CcSEcCtD
Cefotetan—Haemorrhage—Ifosfamide—testicular cancer	0.00511	0.00511	CcSEcCtD
Cefotetan—Thrombocytopenia—Vinblastine—testicular cancer	0.00493	0.00493	CcSEcCtD
Cefotetan—Erythema multiforme—Ifosfamide—testicular cancer	0.00483	0.00483	CcSEcCtD
Cefotetan—Vaginal inflammation—Methotrexate—testicular cancer	0.00482	0.00482	CcSEcCtD
Cefotetan—Pancytopenia—Etoposide—testicular cancer	0.00479	0.00479	CcSEcCtD
Cefotetan—Blood bilirubin increased—Epirubicin—testicular cancer	0.00477	0.00477	CcSEcCtD
Cefotetan—Neutropenia—Etoposide—testicular cancer	0.00472	0.00472	CcSEcCtD
Cefotetan—Leukopenia—Bleomycin—testicular cancer	0.00466	0.00466	CcSEcCtD
Cefotetan—Vaginal infection—Methotrexate—testicular cancer	0.00455	0.00455	CcSEcCtD
Cefotetan—Aplastic anaemia—Methotrexate—testicular cancer	0.00452	0.00452	CcSEcCtD
Cefotetan—Vaginal inflammation—Epirubicin—testicular cancer	0.00451	0.00451	CcSEcCtD
Cefotetan—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00449	0.00449	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Etoposide—testicular cancer	0.00446	0.00446	CcSEcCtD
Cefotetan—Blood bilirubin increased—Doxorubicin—testicular cancer	0.00441	0.00441	CcSEcCtD
Cefotetan—Discomfort—Bleomycin—testicular cancer	0.00438	0.00438	CcSEcCtD
Cefotetan—Urticaria—Chlorambucil—testicular cancer	0.00436	0.00436	CcSEcCtD
Cefotetan—Leukopenia—Dactinomycin—testicular cancer	0.00435	0.00435	CcSEcCtD
Cefotetan—Abdominal pain—Chlorambucil—testicular cancer	0.00434	0.00434	CcSEcCtD
Cefotetan—Body temperature increased—Chlorambucil—testicular cancer	0.00434	0.00434	CcSEcCtD
Cefotetan—Colitis—Epirubicin—testicular cancer	0.00433	0.00433	CcSEcCtD
Cefotetan—Vaginal infection—Epirubicin—testicular cancer	0.00426	0.00426	CcSEcCtD
Cefotetan—Anaphylactic shock—Bleomycin—testicular cancer	0.00425	0.00425	CcSEcCtD
Cefotetan—Aplastic anaemia—Epirubicin—testicular cancer	0.00423	0.00423	CcSEcCtD
Cefotetan—Agranulocytosis—Etoposide—testicular cancer	0.0042	0.0042	CcSEcCtD
Cefotetan—Vaginal inflammation—Doxorubicin—testicular cancer	0.00417	0.00417	CcSEcCtD
Cefotetan—Thrombocytopenia—Bleomycin—testicular cancer	0.00416	0.00416	CcSEcCtD
Cefotetan—Gastrointestinal pain—Vinblastine—testicular cancer	0.00412	0.00412	CcSEcCtD
Cefotetan—Discomfort—Dactinomycin—testicular cancer	0.00409	0.00409	CcSEcCtD
Cefotetan—Hypersensitivity—Chlorambucil—testicular cancer	0.00405	0.00405	CcSEcCtD
Cefotetan—Colitis—Doxorubicin—testicular cancer	0.004	0.004	CcSEcCtD
Cefotetan—Leukopenia—Ifosfamide—testicular cancer	0.00398	0.00398	CcSEcCtD
Cefotetan—Abdominal pain—Vinblastine—testicular cancer	0.00398	0.00398	CcSEcCtD
Cefotetan—Vaginal infection—Doxorubicin—testicular cancer	0.00394	0.00394	CcSEcCtD
Cefotetan—Aplastic anaemia—Doxorubicin—testicular cancer	0.00392	0.00392	CcSEcCtD
Cefotetan—Pruritus—Chlorambucil—testicular cancer	0.00389	0.00389	CcSEcCtD
Cefotetan—Thrombocytopenia—Dactinomycin—testicular cancer	0.00388	0.00388	CcSEcCtD
Cefotetan—Convulsion—Ifosfamide—testicular cancer	0.00386	0.00386	CcSEcCtD
Cefotetan—Erythema multiforme—Etoposide—testicular cancer	0.00382	0.00382	CcSEcCtD
Cefotetan—Phlebitis—Epirubicin—testicular cancer	0.0038	0.0038	CcSEcCtD
Cefotetan—Diarrhoea—Chlorambucil—testicular cancer	0.00376	0.00376	CcSEcCtD
Cefotetan—Hepatic function abnormal—Epirubicin—testicular cancer	0.00374	0.00374	CcSEcCtD
Cefotetan—Discomfort—Ifosfamide—testicular cancer	0.00374	0.00374	CcSEcCtD
Cefotetan—Hypersensitivity—Vinblastine—testicular cancer	0.00371	0.00371	CcSEcCtD
Cefotetan—Anaphylactic shock—Ifosfamide—testicular cancer	0.00363	0.00363	CcSEcCtD
Cefotetan—Thrombocytopenia—Ifosfamide—testicular cancer	0.00356	0.00356	CcSEcCtD
Cefotetan—Phlebitis—Doxorubicin—testicular cancer	0.00351	0.00351	CcSEcCtD
Cefotetan—Vomiting—Chlorambucil—testicular cancer	0.00349	0.00349	CcSEcCtD
Cefotetan—Hepatic function abnormal—Doxorubicin—testicular cancer	0.00346	0.00346	CcSEcCtD
Cefotetan—Diarrhoea—Vinblastine—testicular cancer	0.00344	0.00344	CcSEcCtD
Cefotetan—Leukopenia—Cisplatin—testicular cancer	0.00344	0.00344	CcSEcCtD
Cefotetan—Urticaria—Bleomycin—testicular cancer	0.00338	0.00338	CcSEcCtD
Cefotetan—Body temperature increased—Bleomycin—testicular cancer	0.00336	0.00336	CcSEcCtD
Cefotetan—Convulsion—Cisplatin—testicular cancer	0.00332	0.00332	CcSEcCtD
Cefotetan—Nausea—Chlorambucil—testicular cancer	0.00326	0.00326	CcSEcCtD
Cefotetan—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00324	0.00324	CcSEcCtD
Cefotetan—Discomfort—Cisplatin—testicular cancer	0.00323	0.00323	CcSEcCtD
Cefotetan—Vomiting—Vinblastine—testicular cancer	0.0032	0.0032	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.00315	0.00315	CcSEcCtD
Cefotetan—Leukopenia—Etoposide—testicular cancer	0.00315	0.00315	CcSEcCtD
Cefotetan—Abdominal pain—Dactinomycin—testicular cancer	0.00313	0.00313	CcSEcCtD
Cefotetan—Body temperature increased—Dactinomycin—testicular cancer	0.00313	0.00313	CcSEcCtD
Cefotetan—Anaphylactic shock—Cisplatin—testicular cancer	0.00313	0.00313	CcSEcCtD
Cefotetan—Hypersensitivity—Bleomycin—testicular cancer	0.00313	0.00313	CcSEcCtD
Cefotetan—Thrombocytopenia—Cisplatin—testicular cancer	0.00307	0.00307	CcSEcCtD
Cefotetan—Convulsion—Etoposide—testicular cancer	0.00305	0.00305	CcSEcCtD
Cefotetan—Pruritus—Bleomycin—testicular cancer	0.00301	0.00301	CcSEcCtD
Cefotetan—Eosinophilia—Methotrexate—testicular cancer	0.00299	0.00299	CcSEcCtD
Cefotetan—Nausea—Vinblastine—testicular cancer	0.00299	0.00299	CcSEcCtD
Cefotetan—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00297	0.00297	CcSEcCtD
Cefotetan—Discomfort—Etoposide—testicular cancer	0.00296	0.00296	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.00295	0.00295	CcSEcCtD
Cefotetan—Hypersensitivity—Dactinomycin—testicular cancer	0.00292	0.00292	CcSEcCtD
Cefotetan—Urticaria—Ifosfamide—testicular cancer	0.00289	0.00289	CcSEcCtD
Cefotetan—Body temperature increased—Ifosfamide—testicular cancer	0.00287	0.00287	CcSEcCtD
Cefotetan—Abdominal pain—Ifosfamide—testicular cancer	0.00287	0.00287	CcSEcCtD
Cefotetan—Pancytopenia—Methotrexate—testicular cancer	0.00287	0.00287	CcSEcCtD
Cefotetan—Anaphylactic shock—Etoposide—testicular cancer	0.00287	0.00287	CcSEcCtD
Cefotetan—Neutropenia—Methotrexate—testicular cancer	0.00283	0.00283	CcSEcCtD
Cefotetan—Thrombocytopenia—Etoposide—testicular cancer	0.00281	0.00281	CcSEcCtD
Cefotetan—Eosinophilia—Epirubicin—testicular cancer	0.0028	0.0028	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.00273	0.00273	CcSEcCtD
Cefotetan—Diarrhoea—Dactinomycin—testicular cancer	0.00271	0.00271	CcSEcCtD
Cefotetan—Vomiting—Bleomycin—testicular cancer	0.0027	0.0027	CcSEcCtD
Cefotetan—Pancytopenia—Epirubicin—testicular cancer	0.00269	0.00269	CcSEcCtD
Cefotetan—Rash—Bleomycin—testicular cancer	0.00268	0.00268	CcSEcCtD
Cefotetan—Dermatitis—Bleomycin—testicular cancer	0.00268	0.00268	CcSEcCtD
Cefotetan—Hypersensitivity—Ifosfamide—testicular cancer	0.00268	0.00268	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00267	0.00267	CcSEcCtD
Cefotetan—Neutropenia—Epirubicin—testicular cancer	0.00264	0.00264	CcSEcCtD
Cefotetan—Eosinophilia—Doxorubicin—testicular cancer	0.00259	0.00259	CcSEcCtD
Cefotetan—Pruritus—Ifosfamide—testicular cancer	0.00257	0.00257	CcSEcCtD
Cefotetan—Nausea—Bleomycin—testicular cancer	0.00252	0.00252	CcSEcCtD
Cefotetan—Vomiting—Dactinomycin—testicular cancer	0.00252	0.00252	CcSEcCtD
Cefotetan—Agranulocytosis—Methotrexate—testicular cancer	0.00251	0.00251	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.0025	0.0025	CcSEcCtD
Cefotetan—Rash—Dactinomycin—testicular cancer	0.0025	0.0025	CcSEcCtD
Cefotetan—Diarrhoea—Ifosfamide—testicular cancer	0.00249	0.00249	CcSEcCtD
Cefotetan—Pancytopenia—Doxorubicin—testicular cancer	0.00249	0.00249	CcSEcCtD
Cefotetan—Body temperature increased—Cisplatin—testicular cancer	0.00248	0.00248	CcSEcCtD
Cefotetan—Neutropenia—Doxorubicin—testicular cancer	0.00245	0.00245	CcSEcCtD
Cefotetan—Haemoglobin—Methotrexate—testicular cancer	0.00243	0.00243	CcSEcCtD
Cefotetan—Haemorrhage—Methotrexate—testicular cancer	0.00242	0.00242	CcSEcCtD
Cefotetan—Nausea—Dactinomycin—testicular cancer	0.00235	0.00235	CcSEcCtD
Cefotetan—Agranulocytosis—Epirubicin—testicular cancer	0.00235	0.00235	CcSEcCtD
Cefotetan—Gastrointestinal pain—Etoposide—testicular cancer	0.00235	0.00235	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00231	0.00231	CcSEcCtD
Cefotetan—Vomiting—Ifosfamide—testicular cancer	0.00231	0.00231	CcSEcCtD
Cefotetan—Hypersensitivity—Cisplatin—testicular cancer	0.00231	0.00231	CcSEcCtD
Cefotetan—Rash—Ifosfamide—testicular cancer	0.00229	0.00229	CcSEcCtD
Cefotetan—Dermatitis—Ifosfamide—testicular cancer	0.00229	0.00229	CcSEcCtD
Cefotetan—Erythema multiforme—Methotrexate—testicular cancer	0.00229	0.00229	CcSEcCtD
Cefotetan—Urticaria—Etoposide—testicular cancer	0.00228	0.00228	CcSEcCtD
Cefotetan—Haemoglobin—Epirubicin—testicular cancer	0.00228	0.00228	CcSEcCtD
Cefotetan—Abdominal pain—Etoposide—testicular cancer	0.00227	0.00227	CcSEcCtD
Cefotetan—Body temperature increased—Etoposide—testicular cancer	0.00227	0.00227	CcSEcCtD
Cefotetan—Haemorrhage—Epirubicin—testicular cancer	0.00226	0.00226	CcSEcCtD
Cefotetan—Agranulocytosis—Doxorubicin—testicular cancer	0.00218	0.00218	CcSEcCtD
Cefotetan—Nausea—Ifosfamide—testicular cancer	0.00216	0.00216	CcSEcCtD
Cefotetan—Diarrhoea—Cisplatin—testicular cancer	0.00214	0.00214	CcSEcCtD
Cefotetan—Erythema multiforme—Epirubicin—testicular cancer	0.00214	0.00214	CcSEcCtD
Cefotetan—Hypersensitivity—Etoposide—testicular cancer	0.00211	0.00211	CcSEcCtD
Cefotetan—Haemoglobin—Doxorubicin—testicular cancer	0.00211	0.00211	CcSEcCtD
Cefotetan—Haemorrhage—Doxorubicin—testicular cancer	0.00209	0.00209	CcSEcCtD
Cefotetan—Pruritus—Etoposide—testicular cancer	0.00203	0.00203	CcSEcCtD
Cefotetan—Vomiting—Cisplatin—testicular cancer	0.00199	0.00199	CcSEcCtD
Cefotetan—Erythema multiforme—Doxorubicin—testicular cancer	0.00198	0.00198	CcSEcCtD
Cefotetan—Rash—Cisplatin—testicular cancer	0.00197	0.00197	CcSEcCtD
Cefotetan—Dermatitis—Cisplatin—testicular cancer	0.00197	0.00197	CcSEcCtD
Cefotetan—Diarrhoea—Etoposide—testicular cancer	0.00196	0.00196	CcSEcCtD
Cefotetan—Leukopenia—Methotrexate—testicular cancer	0.00188	0.00188	CcSEcCtD
Cefotetan—Nausea—Cisplatin—testicular cancer	0.00186	0.00186	CcSEcCtD
Cefotetan—Convulsion—Methotrexate—testicular cancer	0.00182	0.00182	CcSEcCtD
Cefotetan—Vomiting—Etoposide—testicular cancer	0.00182	0.00182	CcSEcCtD
Cefotetan—Rash—Etoposide—testicular cancer	0.00181	0.00181	CcSEcCtD
Cefotetan—Dermatitis—Etoposide—testicular cancer	0.00181	0.00181	CcSEcCtD
Cefotetan—Discomfort—Methotrexate—testicular cancer	0.00177	0.00177	CcSEcCtD
Cefotetan—Leukopenia—Epirubicin—testicular cancer	0.00176	0.00176	CcSEcCtD
Cefotetan—Anaphylactic shock—Methotrexate—testicular cancer	0.00172	0.00172	CcSEcCtD
Cefotetan—Convulsion—Epirubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Cefotetan—Nausea—Etoposide—testicular cancer	0.0017	0.0017	CcSEcCtD
Cefotetan—Thrombocytopenia—Methotrexate—testicular cancer	0.00168	0.00168	CcSEcCtD
Cefotetan—Discomfort—Epirubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Cefotetan—Leukopenia—Doxorubicin—testicular cancer	0.00163	0.00163	CcSEcCtD
Cefotetan—Anaphylactic shock—Epirubicin—testicular cancer	0.00161	0.00161	CcSEcCtD
Cefotetan—Convulsion—Doxorubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Cefotetan—Thrombocytopenia—Epirubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Cefotetan—Discomfort—Doxorubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Cefotetan—Anaphylactic shock—Doxorubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Cefotetan—Thrombocytopenia—Doxorubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Cefotetan—Gastrointestinal pain—Methotrexate—testicular cancer	0.00141	0.00141	CcSEcCtD
Cefotetan—Urticaria—Methotrexate—testicular cancer	0.00137	0.00137	CcSEcCtD
Cefotetan—Abdominal pain—Methotrexate—testicular cancer	0.00136	0.00136	CcSEcCtD
Cefotetan—Body temperature increased—Methotrexate—testicular cancer	0.00136	0.00136	CcSEcCtD
Cefotetan—Gastrointestinal pain—Epirubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Cefotetan—Urticaria—Epirubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Cefotetan—Abdominal pain—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Cefotetan—Body temperature increased—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Cefotetan—Hypersensitivity—Methotrexate—testicular cancer	0.00127	0.00127	CcSEcCtD
Cefotetan—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Cefotetan—Pruritus—Methotrexate—testicular cancer	0.00122	0.00122	CcSEcCtD
Cefotetan—Hypersensitivity—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Cefotetan—Urticaria—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Cefotetan—Body temperature increased—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Cefotetan—Abdominal pain—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Cefotetan—Diarrhoea—Methotrexate—testicular cancer	0.00118	0.00118	CcSEcCtD
Cefotetan—Pruritus—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Cefotetan—Diarrhoea—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Cefotetan—Hypersensitivity—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Cefotetan—Vomiting—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Cefotetan—Rash—Methotrexate—testicular cancer	0.00108	0.00108	CcSEcCtD
Cefotetan—Dermatitis—Methotrexate—testicular cancer	0.00108	0.00108	CcSEcCtD
Cefotetan—Pruritus—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Cefotetan—Vomiting—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Cefotetan—Nausea—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Cefotetan—Diarrhoea—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Cefotetan—Rash—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Cefotetan—Dermatitis—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Cefotetan—Nausea—Epirubicin—testicular cancer	0.000955	0.000955	CcSEcCtD
Cefotetan—Vomiting—Doxorubicin—testicular cancer	0.000946	0.000946	CcSEcCtD
Cefotetan—Rash—Doxorubicin—testicular cancer	0.000938	0.000938	CcSEcCtD
Cefotetan—Dermatitis—Doxorubicin—testicular cancer	0.000937	0.000937	CcSEcCtD
Cefotetan—Nausea—Doxorubicin—testicular cancer	0.000884	0.000884	CcSEcCtD
